Pharmafile Logo
Pharmafocus logo
Advanced Search

Sir Andrew Witty

Showing 4 posts of 4 posts found.

gsk_boronia_australia

GlaxoSmithKline opens new £56 million facility in Hertfordshire

April 19, 2016
Manufacturing and Production Andrew Witty, GSK, GlaxoSmithKline, Sir Andrew Witty, ellipta, facility, george freeman, inhalers, manufacturing, new, respiratory, ware

GlaxoSmithKline has opened a new £56 million manufacturing facility in Hertfordshire, South-East England. The facility in Ware will create 150 …

News

Sir Andrew Witty announces decision to step down as CEO of GSK

March 17, 2016
Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …

News
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015
Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …

News
Antonio Tajani

Can Europe really agree to speed up pricing and reimbursement?

March 6, 2012
Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement

The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …

Feature
The Gateway to Local Adoption Series

Latest content

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026

Tridem begins phase Ib trial of Parkinson’s disease vaccine

October 13, 2026

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026

Trio become latest Symbiosis commercial additions

October 12, 2026

UK immunoglobulin supply faces growing pressure, report warns

October 12, 2026